FHIR © HL7.org  |  FHIRsmith 4.0.1  |  Server Home  |  XIG Home  |  XIG Stats  | 

FHIR IG analytics

Packagesmart.who.int.immunizations
Resource TypePlanDefinition
IdPlanDefinition-IMMZD2DTMalaria.json
FHIR VersionR4
Sourcehttps://build.fhir.org/ig/dhes/smart-immunizations/PlanDefinition-IMMZD2DTMalaria.html
URLhttp://smart.who.int/immunizations/PlanDefinition/IMMZD2DTMalaria
Version0.2.0
Statusdraft
Date2025-12-05T23:35:21+00:00
NameIMMZD2DTMalaria
TitleIMMZ.D2.DT.Malaria
Authoritywho
DescriptionIMMZ.D2.DT.Malaria 4-dose schedule (The RTS,S/AS01 malaria vaccine should be used for the prevention of Plasmodium falciparum malaria in children living in regions with moderate to high malaria transmission, as defined by WHO)

Resources that use this resource

No resources found


Resources that this resource uses

No resources found


Narrative

Note: links and images are rebased to the (stated) source

Id: IMMZD2DTMalaria
Url: IMMZ.D2.DT.Malaria
Version: 0.2.0
Title: IMMZ.D2.DT.Malaria
Status: draft
Type:

system: http://terminology.hl7.org/CodeSystem/plan-definition-type

code: eca-rule

Date: 2025-12-05 23:35:21+0000
Publisher: WHO
Description:

IMMZ.D2.DT.Malaria 4-dose schedule (The RTS,S/AS01 malaria vaccine should be used for the prevention of Plasmodium falciparum malaria in children living in regions with moderate to high malaria transmission, as defined by WHO)

Knowledge Capability: computable
Related Artifacts:

References

  • WHO recommendations for routine immunization - summary tables (January 2025)


Libraries:
IMMZD2DTMalariaLogic
Actions:
Determine if the client is due for Malaria.: Determine if the client is due for Malaria vaccine according to the national immunization protocol. 4-dose schedule (The RTS,S/AS01 malaria vaccine should be used for the prevention of Plasmodium falciparum malaria in children living in regions with moderate to high malaria transmission, as defined by WHO)
If: Applicability: Client is due for malaria vaccination (Client is due for malaria vaccination)
Then: Definition: IMMZD2DTMR
Dynamic Values:
status: ('draft')
intent: ('proposal')
medication: (Concept { codes: { Code { system: 'http://smart.who.int/immunizations/CodeSystem/IMMZ.Z', code: 'DE27', display: 'Malaria vaccines' } }, display: 'Malaria vaccines' })
Check for Guidance for the patient regarding IMMZ.D2.DT.Malaria.: Show Guidance for the patient regarding IMMZ.D2.DT.Malaria.
If: Applicability: Has Guidance (Has Guidance)
Then: Definition: IMMZ.D2.DT.CR
Dynamic Values:
status: ('active')
payload.contentString: (Guidance)
category.coding: (Code { system: 'http://terminology.hl7.org/CodeSystem/communication-category', code: 'alert' })
priority: (Code { system: 'http://hl7.org/fhir/request-priority', code: 'routine' })

Source1

{
  "resourceType": "PlanDefinition",
  "id": "IMMZD2DTMalaria",
  "meta": {
    "profile": [
      "http://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-recommendationdefinition",
      "http://hl7.org/fhir/uv/crmi/StructureDefinition/crmi-shareableplandefinition",
      "http://hl7.org/fhir/uv/crmi/StructureDefinition/crmi-publishableplandefinition"
    ]
  },
  "text": {
    "status": "extensions",
    "div": "<!-- snip (see above) -->"
  },
  "extension": [
    {
      "url": "http://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-knowledgeCapability",
      "valueCode": "computable"
    }
  ],
  "url": "http://smart.who.int/immunizations/PlanDefinition/IMMZD2DTMalaria",
  "version": "0.2.0",
  "name": "IMMZD2DTMalaria",
  "title": "IMMZ.D2.DT.Malaria",
  "type": {
    "coding": [
      {
        "system": "http://terminology.hl7.org/CodeSystem/plan-definition-type",
        "code": "eca-rule"
      }
    ]
  },
  "status": "draft",
  "experimental": false,
  "date": "2025-12-05T23:35:21+00:00",
  "publisher": "WHO",
  "contact": [
    {
      "name": "WHO",
      "telecom": [
        {
          "system": "url",
          "value": "http://who.int"
        }
      ]
    }
  ],
  "description": "IMMZ.D2.DT.Malaria\n4-dose schedule (The RTS,S/AS01 malaria vaccine should be used for the prevention of Plasmodium falciparum malaria in children living in regions with moderate to high malaria transmission, as defined by WHO)",
  "relatedArtifact": [
    {
      "type": "citation",
      "citation": "WHO recommendations for routine immunization - summary tables (January 2025)"
    }
  ],
  "library": [
    "http://smart.who.int/immunizations/Library/IMMZD2DTMalariaLogic"
  ],
  "action": [
    {
      "extension": [
        {
          "url": "http://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-rationale",
          "valueMarkdown": "The vaccine should be administered in a 3-dose primary schedule, with a fourth dose \nprovided approximately 12–18 months after the third dose to prolong the duration of protection. \nThere should be a minimum interval of 4 weeks between doses."
        }
      ],
      "title": "Determine if the client is due for Malaria.",
      "description": "Determine if the client is due for Malaria vaccine according to the national immunization protocol.\n4-dose schedule (The RTS,S/AS01 malaria vaccine should be used for the prevention of Plasmodium \nfalciparum malaria in children living in regions with moderate to high malaria transmission, as \ndefined by WHO)",
      "condition": [
        {
          "kind": "applicability",
          "expression": {
            "description": "Client is due for malaria vaccination",
            "language": "text/cql-identifier",
            "expression": "Client is due for malaria vaccination"
          }
        }
      ],
      "definitionCanonical": "http://smart.who.int/immunizations/ActivityDefinition/IMMZD2DTMR",
      "dynamicValue": [
        {
          "path": "status",
          "expression": {
            "language": "text/cql-expression",
            "expression": "'draft'"
          }
        },
        {
          "path": "intent",
          "expression": {
            "language": "text/cql-expression",
            "expression": "'proposal'"
          }
        },
        {
          "path": "medication",
          "expression": {
            "language": "text/cql-expression",
            "expression": "Concept { codes: { Code { system: 'http://smart.who.int/immunizations/CodeSystem/IMMZ.Z', code: 'DE27', display: 'Malaria vaccines' } }, display: 'Malaria vaccines' }"
          }
        }
      ]
    },
    {
      "title": "Check for Guidance for the patient regarding IMMZ.D2.DT.Malaria.",
      "description": "Show Guidance for the patient regarding IMMZ.D2.DT.Malaria.",
      "condition": [
        {
          "kind": "applicability",
          "expression": {
            "description": "Has Guidance",
            "language": "text/cql-identifier",
            "expression": "Has Guidance"
          }
        }
      ],
      "definitionCanonical": "http://smart.who.int/immunizations/ActivityDefinition/IMMZD2DTCR",
      "dynamicValue": [
        {
          "path": "status",
          "expression": {
            "language": "text/cql-expression",
            "expression": "'active'"
          }
        },
        {
          "path": "payload.contentString",
          "expression": {
            "language": "text/cql-identifier",
            "expression": "Guidance"
          }
        },
        {
          "path": "category.coding",
          "expression": {
            "description": "Category of communication",
            "language": "text/cql-expression",
            "expression": "Code { system: 'http://terminology.hl7.org/CodeSystem/communication-category', code: 'alert' }"
          }
        },
        {
          "path": "priority",
          "expression": {
            "description": "Alert priority",
            "language": "text/cql-expression",
            "expression": "Code { system: 'http://hl7.org/fhir/request-priority', code: 'routine' }"
          }
        }
      ]
    }
  ]
}